Jorhat, India

Bishwajit Saikia

This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bishwajit Saikia. Retrieved from https://idiyas.com/inventor/bishwajit-saikia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Bishwajit Saikia in Cancer Research

Introduction

Bishwajit Saikia is a notable inventor based in Jorhat, India. He has made significant contributions to the field of cancer research through his innovative work on artemisinin compounds. His research focuses on developing new compounds that can potentially combat various cancer cell lines.

Latest Patents

Bishwajit Saikia holds a patent for "1,2,3-triazole containing artemisinin compounds and process for preparation thereof." This invention relates to the synthesis and bioassay results of artemisinin-derived compounds. The compounds are produced through a 1,3-dipolar cycloaddition reaction of artemisinin-derived azide or alkyne with aliphatic or aromatic diazides. The resulting 1,2,3-triazole containing artemisinin derived compounds have shown activity against various cancer cell lines.

Career Highlights

Bishwajit Saikia is associated with the Council of Scientific and Industrial Research, where he continues to advance his research in medicinal chemistry. His work has garnered attention for its potential applications in cancer treatment.

Collaborations

Some of his notable coworkers include Paruchuri Gangadhar Rao and Ajit Kumar Saxena. Their collaborative efforts contribute to the ongoing research and development in the field.

Conclusion

Bishwajit Saikia's innovative work in developing artemisinin compounds represents a significant advancement in cancer research. His contributions may pave the way for new therapeutic options in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…